Literature DB >> 17664200

Surgical results in bronchiectasis: analysis of 149 patients.

Thomas Stephen1, Roy Thankachen, Andrew P Madhu, Nithya Neelakantan, Vinayak Shukla, Roy J Korula.   

Abstract

Bronchiectasis remains a serious problem in developing countries. We reviewed the morbidity, mortality, and functional outcome of surgical treatment for bronchiectasis in our institution. Between 1992 and 2003, 149 patients (105 males, 44 females) underwent pulmonary resection for bronchiectasis. Their mean age was 33.7 years (range, 5-66 years). The indications for surgery were failure of conservative treatment in 59 (40%) patients, recurrent hemoptysis in 53 (36%), bronchial obstruction by a tumor in 9 (6%), and destroyed lung in 28 (19%). Bilateral disease was seen in 24 (16%) patients. Surgical treatment included pneumonectomy in 55 (37%) patients, lobectomy in 55 (37%), bilobectomy in 37 (25%), and lobectomy and/or segmentectomy in 2 (1%). There was one operative death (mortality, 0.67%) and morbidity occurred in 22 (14.8%) patients. Follow-up was complete in 94 patients, for a mean of 4.8 years (range, 3 months to 12 years). After surgery, 51 (34%) patients were asymptomatic. Surgical treatment for bronchiectasis can achieve good results with acceptable morbidity and mortality, not only in localized disease but also in extensive disease, if complete resection can be achieved.

Entities:  

Mesh:

Year:  2007        PMID: 17664200     DOI: 10.1177/021849230701500405

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  9 in total

1.  Surgical resection is an effective treatment of bronchiectasis in selected patients.

Authors:  Tomas Gudbjartsson
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  Surgical treatment of bronchiectasis: a retrospective observational study of 138 patients.

Authors:  Reda E Al-Refaie; Sameh Amer; Mohamed El-Shabrawy
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

3.  Surgical management of bronchiectasis: the indications and outcomes.

Authors:  Soner Gursoy; Ali Ata Ozturk; Ahmet Ucvet; Ahmet Emin Erbaycu
Journal:  Surg Today       Date:  2009-12-29       Impact factor: 2.549

4.  Surgery for bronchiectasis: The effect of morphological types to prognosis.

Authors:  Ufuk Cobanoglu; Irfan Yalcinkaya; Metin Er; Ahmet Feridun Isik; Fuat Sayir; Duygu Mergan
Journal:  Ann Thorac Med       Date:  2011-01       Impact factor: 2.219

5.  A long-term study assessing the factors influencing survival and morbidity in the surgical management of bronchiectasis.

Authors:  Abidin Sehitogullari; Salim Bilici; Fuat Sayir; Ufuk Cobanoglu; Ali Kahraman
Journal:  J Cardiothorac Surg       Date:  2011-12-11       Impact factor: 1.637

Review 6.  Efficiency and safety of surgical intervention to patients with Non-Cystic Fibrosis bronchiectasis: a meta-analysis.

Authors:  Li-Chao Fan; Shuo Liang; Hai-Wen Lu; Ke Fei; Jin-Fu Xu
Journal:  Sci Rep       Date:  2015-12-02       Impact factor: 4.379

7.  In Vivo Effects of Salbutamol Residues on Blood Lipid, Lung Structure, Gene Expression, and Gut Microorganism Composition.

Authors:  Zhaoyang Wang; Yan Lv; Diya Zhang; Haohao Liu; Lisha Dong; Tinghong Ming; Xiurong Su
Journal:  ACS Omega       Date:  2019-11-20

8.  The Efficacy and Safety of Surgical Treatment for Patients With Tuberculosis Destroyed Lung With or Without Chronic Pulmonary Aspergillosis.

Authors:  Hongyun Ruan; Changfan Gong; Jinxiang Wang
Journal:  World J Surg       Date:  2021-02-08       Impact factor: 3.352

9.  Long-term follow-up of tuberculosis-destroyed lung patients after surgical treatment.

Authors:  Hongyun Ruan; Fangchao Liu; Yunsong Li; Yuxuan Wang; Dongdong Hou; Xinting Yang; Bin Liu; Teng Ma; Zhidong Liu
Journal:  BMC Pulm Med       Date:  2022-09-14       Impact factor: 3.320

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.